Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia
- PMID: 1961755
- PMCID: PMC53029
- DOI: 10.1073/pnas.88.23.10850
Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia
Abstract
A variety of cytoarchitectural disturbances have been described in limbic regions in postmortem studies of schizophrenia, many of which suggest a developmental disturbance of normal neuronal geometry. This geometry is established and maintained by elements of the neuronal cytoskeleton. Immunohistochemistry with a panel of 15 monoclonal antibodies was used to monitor the presence of neuronal cytoskeletal proteins in the hippocampal formations of six patients with schizophrenia, six normal controls, and six with neurodegenerative disorders. In five of the six subjects with schizophrenia, prominent and specific alterations were found in the distribution of two microtubule-associated proteins, MAP2 and MAP5, which were anatomically selective for the subiculum and entorhinal cortex. In contrast, the immunoreactivity of other cytoskeletal proteins (i.e., tau, tubulins, and selected neurofilament protein phosphoisoforms) was similar for all subjects. Defects in the expression of MAP2 and MAP5, two proteins that contribute to the establishment and maintenance of neuronal polarity, could underlie some of the cytoarchitectural abnormalities described in schizophrenia and impair signal transduction in the affected dendrites. The subiculum and entorhinal cortex interconnect the hippocampal formation with widespread cortices and subcortical nuclei and play important roles in higher cognitive functions. Hence, pathologic lesions that distort the polarized geometry of neurons could play a role in the emergence of aberrant behavior in schizophrenia.
Similar articles
-
Human fetal hippocampal development: II. The neuronal cytoskeleton.J Comp Neurol. 1996 Apr 1;367(2):293-307. doi: 10.1002/(SICI)1096-9861(19960401)367:2<293::AID-CNE10>3.0.CO;2-S. J Comp Neurol. 1996. PMID: 8708011
-
Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia.Brain Res. 1997 Aug 15;765(2):238-46. doi: 10.1016/s0006-8993(97)00575-1. Brain Res. 1997. PMID: 9313896
-
Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines.Am J Psychiatry. 2004 Oct;161(10):1848-55. doi: 10.1176/ajp.161.10.1848. Am J Psychiatry. 2004. PMID: 15465982
-
Cellular and molecular neuropathology of the parahippocampal region in schizophrenia.Ann N Y Acad Sci. 2000 Jun;911:275-92. doi: 10.1111/j.1749-6632.2000.tb06732.x. Ann N Y Acad Sci. 2000. PMID: 10911880 Review.
-
Microtubule and microtubule associated protein anomalies in psychiatric disease.Cytoskeleton (Hoboken). 2016 Oct;73(10):596-611. doi: 10.1002/cm.21300. Epub 2016 May 20. Cytoskeleton (Hoboken). 2016. PMID: 27112918 Review.
Cited by
-
Understanding schizophrenia as a disorder of consciousness: biological correlates and translational implications from quantum theory perspectives.Clin Psychopharmacol Neurosci. 2015 Apr 30;13(1):36-47. doi: 10.9758/cpn.2015.13.1.36. Clin Psychopharmacol Neurosci. 2015. PMID: 25912536 Free PMC article.
-
The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.Psychopharmacology (Berl). 2004 Jun;174(1):151-62. doi: 10.1007/s00213-003-1761-y. Epub 2004 Mar 6. Psychopharmacology (Berl). 2004. PMID: 15205886 Review.
-
Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia.Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14182-7. doi: 10.1073/pnas.93.24.14182. Proc Natl Acad Sci U S A. 1996. PMID: 8943081 Free PMC article.
-
Synapsin III acts downstream of semaphorin 3A/CDK5 signaling to regulate radial migration and orientation of pyramidal neurons in vivo.Cell Rep. 2015 Apr 14;11(2):234-48. doi: 10.1016/j.celrep.2015.03.022. Epub 2015 Apr 2. Cell Rep. 2015. PMID: 25843720 Free PMC article.
-
Receptor-Independent Therapies for Forensic Detainees with Schizophrenia-Dementia Comorbidity.Int J Mol Sci. 2023 Oct 31;24(21):15797. doi: 10.3390/ijms242115797. Int J Mol Sci. 2023. PMID: 37958780 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical